David Rolfe - Wedgewood Partners
Holding/activity history for  Bristol-Myers Squibb Rights (BMY.R)
Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
2020   Q4 | 0 | 0 | Sell 100.00% | 0.05 | |
2020   Q3 | 131,557 | 0.05 | Reduce 2.35% | 0.00 | $2.24 |
2020   Q2 | 134,729 | 0.08 | Reduce 9.52% | 0.01 | $3.57 |
2020   Q1 | 148,901 | 0.11 | Buy | 0.11 | $3.79 |